Similar articles

• Simultaneous liquid-chromatographic determination of plasma catecholamines and metabolites.

  Eisenhofer G, Goldstein D, Kopin I. Eisenhofer G, et al. Clin Chem. 2009 Dec;55(12):2223-4. doi: 10.1373/clinchem.2009.134478. Epub 2009 Oct 15. Clin Chem. 2009. PMID: 19833834 No abstract available.
• Simultaneous measurement of DOPA, DOPAC, and catecholamines in plasma by liquid chromatography with electrochemical detection.

  Goldstein DS, Stull R, Zimlichman R, Levinson PD, Smith H, Keiser HR. Goldstein DS, et al. Clin Chem. 1984 May;30(5):815-6. Clin Chem. 1984. PMID: 6424968 No abstract available.
• Simultaneous liquid-chromatographic determination of 3,4-dihydroxyphenylglycol, catecholamines, and 3,4-dihydroxyphenylalanine in plasma, and their responses to inhibition of monoamine oxidase.

  Eisenhofer G, Goldstein DS, Stull R, Keiser HR, Sunderland T, Murphy DL, Kopin IJ. Eisenhofer G, et al. Clin Chem. 1986 Nov;32(11):2030-3. Clin Chem. 1986. PMID: 3096593
• Sources and significance of plasma levels of catechols and their metabolites in humans.

  Goldstein DS, Eisenhofer G, Kopin IJ. Goldstein DS, et al. J Pharmacol Exp Ther. 2003 Jun;305(3):800-11. doi: 10.1124/jpet.103.049270. Epub 2003 Mar 20. J Pharmacol Exp Ther. 2003. PMID: 12649306 Review.
• Origin and significance of plasma dihydroxyphenylalanine.

  Eldrup E, Richter EA, Hetland ML, Andreasen J, Hilsted J, Møller SE, Christensen NJ. Eldrup E, et al. Adv Pharmacol. 1998;42:851-4. doi: 10.1016/s1054-3589(08)60880-7. Adv Pharmacol. 1998. PMID: 9328031 Review. No abstract available.